Anca Grosu
#123,916
Most Influential Person Now
Romanian-German radiation oncologist
Anca Grosu's AcademicInfluence.com Rankings
Anca Grosumedical Degrees
Medical
#1987
World Rank
#2376
Historical Rank
Oncology
#148
World Rank
#154
Historical Rank
Download Badge
Medical
Anca Grosu's Degrees
- Doctorate Medicine University of Bucharest
Why Is Anca Grosu Influential?
(Suggest an Edit or Addition)According to Wikipedia, Anca-Ligia Grosu is a Romanian-German radiation oncologist and professor with a research focus on the development of personalized therapy in radiation oncology. She is chair of the Radiation Oncology Department at the University Medical Center Freiburg, Germany, and member of the German National Academy of Sciences Leopoldina.
Anca Grosu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. (2010) (374)
- O-(2-[18F]Fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study (2000) (361)
- Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. (2004) (345)
- Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man (2006) (303)
- ESTRO-ACROP guideline "target delineation of glioblastomas". (2016) (252)
- Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. (2019) (238)
- L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. (2005) (233)
- Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. (2007) (227)
- An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. (2011) (210)
- [18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck (2007) (209)
- Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. (2006) (208)
- ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams (2019) (205)
- Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. (2005) (200)
- Positron Emission Tomography for Radiation Treatment Planning (2005) (190)
- Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. (2006) (171)
- Presentation, patterns of care, and survival in patients with brain metastases (2011) (169)
- Biological imaging in radiation therapy: role of positron emission tomography (2009) (166)
- Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study (2007) (161)
- PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. (2006) (141)
- Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. (2005) (137)
- PET imaging in patients with meningioma—report of the RANO/PET Group (2017) (135)
- HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2014) (129)
- Stereotactic radiosurgery (SRS) for brain metastases: a systematic review (2014) (126)
- Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology (2017) (123)
- Stereotactic radiosurgery for treatment of brain metastases (2014) (121)
- Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer. (2012) (120)
- Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors (2011) (118)
- Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. (2006) (117)
- Therapeutic options for recurrent high-grade glioma in adult patients: recent advances. (2006) (115)
- Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning (2008) (114)
- Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG (2016) (105)
- Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience. (2003) (104)
- HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2016) (100)
- PET for radiation treatment planning of brain tumours. (2010) (96)
- 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. (2006) (93)
- Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only (2015) (92)
- Chloroquine or Chloroquine-PI3K/Akt Pathway Inhibitor Combinations Strongly Promote γ-Irradiation-Induced Cell Death in Primary Stem-Like Glioma Cells (2012) (89)
- Improvement, Clinical Course, and Quality of Life After Palliative Radiotherapy for Recurrent Glioblastoma (2008) (88)
- Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications. (2016) (87)
- The PD‐1/PD‐L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG) (2017) (87)
- SBRT in pancreatic cancer: what is the therapeutic window? (2015) (85)
- Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. (2008) (85)
- Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference (2019) (83)
- Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells (2014) (82)
- First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. (2000) (82)
- Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery (2020) (81)
- 68Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison (2016) (80)
- Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? (2004) (79)
- Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. (2013) (76)
- Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study. (2019) (73)
- Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome. (2015) (73)
- Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas. (2002) (73)
- Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts. (2013) (72)
- Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial. (2020) (72)
- Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers. (2015) (72)
- [A chemical inhibitor of p53 that protects mice from the side effects of cancer treatment]. (2000) (69)
- Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. (2021) (68)
- Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases (2015) (67)
- Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525 (2017) (67)
- Radiotherapy for High-Grade Gliomas (2004) (67)
- Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies (2016) (64)
- MRI versus 68Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer (2016) (62)
- [68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancer. (2019) (60)
- Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer - a systematic review. (2015) (60)
- Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution. (2011) (59)
- Outcome After PSMA PET/CT–Based Salvage Radiotherapy in Patients with Biochemical Recurrence After Radical Prostatectomy: A 2-Institution Retrospective Analysis (2018) (58)
- Retreatment of the spinal cord with palliative radiotherapy. (2002) (55)
- Recursive Partitioning Analysis (RPA) Class Does Not Predict Survival in Patients with Four or More Brain Metastases (2001) (55)
- Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil (2012) (54)
- Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1) (2016) (54)
- 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study (2013) (53)
- Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens (2013) (51)
- Re-irradiation for Recurrent Primary Brain Tumors. (2016) (51)
- Correlation Between Postoperative 3-[123I]Iodo-l-α-Methyltyrosine Uptake and Survival in Patients with Gliomas (2001) (51)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (50)
- Stereotactic fractionated radiotherapy for Klatskin tumours. (2010) (50)
- A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection (2018) (49)
- [18F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients – A Review (2013) (49)
- Recent advances of PET imaging in clinical radiation oncology (2020) (49)
- The diagnosis and treatment of soft tissue sarcomas of the limbs. (2011) (47)
- Treatment of unresectable glioblastoma multiforme. (2005) (46)
- Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms. (2018) (46)
- Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group. (2021) (45)
- Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG) (2017) (45)
- Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference (2018) (45)
- Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference. (2017) (44)
- Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation (2018) (44)
- Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly? (2020) (44)
- Impact of 4D-(18)FDG-PET/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study. (2015) (43)
- Stereotactic body radiotherapy for centrally located stage I NSCLC (2014) (41)
- Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma (2017) (41)
- Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990 (2013) (40)
- Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy (2018) (39)
- A deep conical agarose microwell array for adhesion independent three-dimensional cell culture and dynamic volume measurement. (2017) (39)
- Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastoma. (2008) (39)
- Non-Invasive In Vivo Imaging of Tumor-Associated CD133/Prominin (2010) (38)
- Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT (2017) (38)
- Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA) (2017) (37)
- PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (37)
- Tumor Shrinkage Assessed by Volumetric MRI in the Long-Term Follow-Up after Stereotactic Radiotherapy of Meningiomas (2010) (36)
- Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. (2014) (36)
- Stereotactic Fractionated Radiotherapy for Recurrent Capillary Hemangioma of the Cavernous Sinus (2006) (35)
- The Role of Postoperative Radiotherapy after Resection of a Single Brain Metastasis (2007) (35)
- Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference. (2019) (34)
- 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas. (2007) (34)
- PET-Based Human Dosimetry of 18F-Galacto-RGD, a New Radiotracer for Imaging avb3 Expression (2006) (33)
- Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis. (2018) (32)
- Extensive local and systemic therapy in extraneural metastasized glioblastoma multiforme. (2006) (32)
- Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma (2017) (32)
- Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation. (2019) (32)
- Description of a method: computer generated virtual model for accurate localisation of tumour margins, standardised resection, and planning of radiation treatment in head & neck cancer surgery. (2013) (31)
- Expert consensus on re-irradiation for recurrent glioma (2017) (31)
- Simultaneous integrated protection (2016) (30)
- Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-14, ARO 2015–3, DKTK-ROG) (2020) (30)
- Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma? (2011) (29)
- Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy (2013) (29)
- A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer (2015) (28)
- Influence of experience and qualification on PET-based target volume delineation (2014) (28)
- A Novel MiRNA-Based Predictive Model for Biochemical Failure Following Post-Prostatectomy Salvage Radiation Therapy (2015) (27)
- Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. (2001) (27)
- Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) (2018) (27)
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis (2018) (27)
- High-Precision Radiation Therapy with Integrated Biological Imaging and Tumor Monitoring (2006) (27)
- Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer (2020) (26)
- Hippocampus‐avoidance whole‐brain radiation therapy with a simultaneous integrated boost for multiple brain metastases (2020) (26)
- 11C-Choline PET/pathology image coregistration in primary localized prostate cancer (2014) (26)
- The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer. (2020) (26)
- Irradiation for Conjunctival Granulocytic Sarcoma (2003) (25)
- Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles. (2013) (25)
- Diagnostics of cerebral gliomas with radiolabeled amino acids. (2008) (25)
- Combined wIRA-Hyperthermia and Hypofractionated Re-Irradiation in the Treatment of Locally Recurrent Breast Cancer: Evaluation of Therapeutic Outcome Based on a Novel Size Classification (2020) (25)
- Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET (2018) (24)
- Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma. (2019) (24)
- Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments. (2020) (24)
- Tumor shrinkage assessed by volumetric MRI in long-term follow-up after fractionated stereotactic radiotherapy of nonfunctioning pituitary adenoma. (2012) (24)
- Combined modality treatment of glioblastoma multiforme: the role of temozolomide. (2006) (24)
- Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies (2012) (24)
- Stereotactic ablative radiotherapy for small lung tumors with a moderate dose (2012) (24)
- Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients (2020) (23)
- Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous (2019) (23)
- VMAT and Step-and-Shoot IMRT in Head and Neck Cancer (2011) (23)
- Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (22)
- Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy (2016) (22)
- Radiotherapy and Chemotherapy for Myoepithelioma of the Sellar Region (2005) (22)
- Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer (2016) (22)
- SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy. (2017) (22)
- Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries (2012) (22)
- The role of growth factors in central nervous system tumours. (2003) (21)
- Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases (2018) (21)
- Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process. (2015) (21)
- Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology. (2018) (21)
- The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy (2018) (20)
- Experience of PET for target localisation in radiation oncology (2005) (20)
- Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases (2016) (20)
- The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer (2018) (20)
- Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network (2020) (20)
- Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies (2021) (20)
- Assessment of tumor volumes in skull base glomus tumors using Gluc-Lys[(18)F]-TOCA positron emission tomography. (2009) (19)
- Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents (2004) (19)
- ESTRO ACROP guideline for target volume delineation of skull base tumors. (2020) (19)
- Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries (2019) (19)
- Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial (2019) (19)
- The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage (2019) (18)
- Validation of a method for automatic image fusion of CT-data and C11-methionin-PET data for stereotactic radiotherapy using a LINAC (BrainLAB System). First clinical results (2002) (18)
- FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma (2014) (18)
- Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation. (2020) (18)
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (18)
- The role of postoperative radiotherapy after resection of a single brain metastasis: Combined analysis of 497 patients (2007) (18)
- Local control and overall survival after frameless radiosurgery: A single center experience (2017) (17)
- Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. (2017) (17)
- Three-dimensional conformal versus intensity-modulated radiotherapy dose planning in stereotactic radiotherapy: Application of standard quality parameters for plan evaluation (2006) (17)
- Treatment of recurrent prostate cancer following radical prostatectomy: the radiation-oncologists point of view. (2012) (17)
- De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond (2021) (17)
- Predicted survival in patients with brain metastases from colorectal cancer: Is a current nomogram helpful? (2016) (17)
- PET and SPECT for radiation treatment planning. (2012) (17)
- Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation (2020) (17)
- Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference (2020) (16)
- Preserving the legacy of reirradiation: A narrative review of historical publications (2017) (16)
- Digital Follow-Up and the Perspective of Patient-Centered Care in Oncology: What’s the PROblem? (2018) (16)
- Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy (2019) (16)
- SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy (2017) (16)
- Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer (2014) (16)
- Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors (2006) (16)
- Second re-irradiation: a narrative review of the available clinical data (2017) (16)
- How to use functional imaging information for radiotherapy planning. (2009) (15)
- Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer (2017) (15)
- The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer (2020) (15)
- Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study (2020) (15)
- FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy (2021) (15)
- Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection (2018) (15)
- Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy. (2019) (14)
- Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection (2018) (14)
- Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature (2020) (14)
- Convolutional neural networks for head and neck tumor segmentation on 7-channel multiparametric MRI: a leave-one-out analysis (2020) (14)
- Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram? (2017) (13)
- [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine. (2014) (13)
- Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer (2020) (13)
- FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? (2021) (13)
- Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy. (2019) (13)
- Prospective randomized clinical studies involving reirradiation (2016) (13)
- Paravertebral Muscle Training in Patients with Unstable Spinal Metastases Receiving Palliative Radiotherapy: An Exploratory Randomized Feasibility Trial (2019) (13)
- Repeated SBRT for in- and out-of-field recurrences in the liver (2018) (13)
- Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): Results of the phase II STRIPE trial. (2020) (13)
- Glioblastoma research 2006–2010: Pattern of citation and systematic review of highly cited articles (2012) (12)
- The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers (2020) (12)
- The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts (2012) (12)
- PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases. (2016) (12)
- Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy (2020) (12)
- Automatic Tumor Segmentation With a Convolutional Neural Network in Multiparametric MRI: Influence of Distortion Correction (2019) (12)
- Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial (2020) (12)
- On the Accuracy of Isocenter Verification with kV Imaging in Stereotactic Radiosurgery (2009) (11)
- Stereotactic Radiotherapy/Radiosurgery (2006) (11)
- Definition of Target Volume and Organs at Risk. Biological Target Volume (2006) (11)
- The challenge of durable brain control in patients with brain-only metastases from breast cancer (2015) (11)
- Effects of Irradiation on the [Methyl-3H]Choline Uptake in the Human Prostate Cancer Cell Lines LNCaP and PC3 (2008) (11)
- Target Volume Definition in Radiation Oncology (2015) (11)
- PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial (2021) (11)
- Early Impact of Pulmonary Fractionated Stereotactic Body Radiotherapy on Quality of Life:Benefit for Patients With Low Initial Scores (STRIPE Trial) (2019) (11)
- Tirapazamine plus cisplatin and irradiation in a mouse model: improved tumor control at the cost of increased toxicity (2007) (11)
- The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer (2021) (11)
- Reirradiation plus EGFR inhibition in locally recurrent and unresectable head and neck cancer (2013) (10)
- Effect of additional inhibition of human epidermal growth factor receptor 2 with the bispecific tyrosine kinase inhibitor AEE788 on the resistance to specific EGFR inhibition in glioma cells. (2010) (10)
- Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 Trial (2020) (10)
- [3-Dimensional irradiation planning in brain tumors. The advantages of the method and the clinical results]. (1998) (10)
- Correlative Analyses between Tissue-Based Hypoxia Biomarkers and Hypoxia PET Imaging in Head and Neck Cancer Patients during Radiochemotherapy: Results from a Prospective Trial (2019) (10)
- Analysis of long-term survivors of glioblastoma multiforme in a single institution with aggressive local retreatment protocol. (2007) (10)
- 18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy (2021) (10)
- FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro (2020) (10)
- [Department and patient management in radiotherapy. The Freiburg model]. (2009) (10)
- Biological imaging in radiation oncology. (2005) (9)
- Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. (2021) (9)
- Brain Metastases Research 1990–2010: Pattern of Citation and Systematic Review of Highly Cited Articles (2012) (9)
- Long-term survival results after treatment for oligometastatic brain disease. (2020) (9)
- Radiotherapy for nonagenarians: the value of biological versus chronological age (2020) (9)
- O-(2-(18F)Fluorethyl)-L-Tyrosine Compared to L-(Methyl-11C) Methionine in Positron Emissions Tomography for Tumor Volume Delineation of Gliomas and Metastases (2005) (8)
- Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo (2015) (8)
- Human mesenchymal stem cells are resistant to UV-B irradiation (2019) (8)
- App-Controlled Treatment Monitoring and Support for Head and Neck Cancer Patients (APCOT): Protocol for a Prospective Randomized Controlled Trial (2020) (8)
- Clipping of tumour resection margins allows accurate target volume delineation in head and neck cancer adjuvant radiation therapy. (2015) (8)
- Multimodal imaging for radiation therapy planning in patients with primary prostate cancer (2018) (8)
- Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference (2021) (8)
- Integration der Bestrahlungsplanung in den volldigitalen Workflow (2013) (8)
- Furosemide diminishes 18F-fluoroethylcholine uptake in prostate cancer in vivo (2014) (8)
- Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer (2020) (8)
- Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy. (2022) (8)
- Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors. (2006) (7)
- Comparison of PET/CT and whole-mount histopathology sections of the human prostate: a new strategy for voxel-wise evaluation (2017) (7)
- Development of a Score Predicting Survival after Palliative Reirradiation (2014) (7)
- PALLIATION OF ESOPHAGEAL CANCER: Endoluminal brachytherapy (1996) (7)
- Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases (2012) (7)
- Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA) (2018) (7)
- Evaluation of the SUV values calculation and 4D PET integration in the radiotherapy treatment planning system. (2011) (7)
- Assessment of extracranial metastatic disease in patients with brain metastases: how much effort is needed in the context of evolving survival prediction models? (2021) (7)
- Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland (2022) (7)
- Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer – a prospective pilot study (2020) (6)
- MRI and FDG-PET/CT imaging in gynecological malignancies: the radiation oncology perspective. (2016) (6)
- Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects. (2018) (6)
- Interobserver variability in target volume delineation of hepatocellular carcinoma (2017) (6)
- PET/MRI and brain tumors: focus on radiation oncology treatment planning (2017) (6)
- Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis (2020) (6)
- Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy (2019) (6)
- Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study (2021) (6)
- Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy? (2021) (6)
- Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models (2022) (6)
- Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition (2020) (6)
- Phase II trial of functional imaging-optimized stereotactic fractionated radiotherapy plus temozolomide for recurrent high-grade glioma. (2004) (6)
- Neuroimaging for Radiation Therapy of Brain Tumors (2019) (6)
- Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. (2019) (5)
- Radiotherapeutic management of cervical lymph node metastases from an unknown primary site – experiences from a large cohort treated with modern radiation techniques (2020) (5)
- GRPR antagonist 68Ga-RM2 as PET tracer for imaging prostate cancer: Initial experiences (2014) (5)
- Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial. (2021) (5)
- Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG. (2022) (5)
- Hippocampus-Avoidance Whole-Brain Radiation Therapy Is Efficient in the Long-Term Preservation of Hippocampal Volume (2021) (5)
- Phase II HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma. (2019) (5)
- Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma. (2020) (5)
- The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer (2020) (5)
- Evaluation of late neurologic adverse events in patients with brain metastases from non-small cell lung cancer. (2007) (5)
- DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis (2022) (5)
- Hypoxia Imaging with 18F-FAZA-PET for Dose Painting Using Intensity Modulated Radiotherapy in Patients with Head and Neck Cancer (2005) (5)
- Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study (2022) (5)
- Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial (2020) (5)
- A systematic review of antiproton radiotherapy (2014) (5)
- Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis (2021) (5)
- Carcinomatous Meningitis Appearing as Acoustic Neuromas (2007) (4)
- Brain metastases in patients under 50 years of age: retrospective analysis (2012) (4)
- Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? (2017) (4)
- Influence of inhomogeneous radiosensitivity distributions and intrafractional organ movement on the tumour control probability of focused IMRT in prostate cancer. (2018) (4)
- Molecular radiobiology meets clinical radiation oncology (2010) (4)
- Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study (2022) (4)
- Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region. (2020) (4)
- Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) Randomized HD11 Trial (2010) (4)
- DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment (2022) (4)
- Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations (2021) (4)
- Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease (2020) (4)
- Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI—A Correlation Study With Whole Mount Histopathological Information as Reference (2020) (4)
- PET and SPECT in Three-Dimensional Treatment Planning of Brain Gliomas (2000) (4)
- Landmark Studies in Radiation Oncology: Has the Pattern of Publication Changed? (2013) (4)
- Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking (2022) (4)
- Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA) (2020) (4)
- Mutational patterns of HPV+ and HPV- squamous cell carcinomas of the head and neck (SCCHN) and their interference with outcome after adjuvant chemoradiation: A multicenter biomarker study of the German Cancer Consortium Radiation Oncology Group. (2015) (4)
- The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation (2023) (4)
- ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy (2020) (4)
- [The situation of radiation oncology patients' relatives. A stocktaking]. (2010) (4)
- Focal Radiotherapy of Brain Metastases in Combination With Immunotherapy and Targeted Drug Therapy. (2021) (3)
- Analyses of molecular subtypes and their association to mechanisms ofradioresistance in patients with HPV-negative HNSCC treated bypostoperative radiochemotherapy. (2022) (3)
- The impact of radiotherapy protocol adherence on the outcome of patients with locally advanced NSCLC treated with concurrent chemoradiation: results from the radiotherapy quality assurance of the multicentre international randomized PET-Plan trial. (2021) (3)
- Brain metastases in renal cell cancer: diagnostic and therapeutic aspects. (2004) (3)
- Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy (2022) (3)
- Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG). (2022) (3)
- Characterization of health-related quality of life based on the EQ-5D-5L questionnaire in head-and-neck cancer patients undergoing modern radiotherapy (2020) (3)
- Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients (2022) (3)
- [Integration of the radiotherapy irradiation planning in the digital workflow]. (2013) (3)
- Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study) (2021) (3)
- [Survey of potential improvements during the course of the radiotherapy treatment--a patient questionnaire]. (2011) (3)
- [Stereotactic convergence irradiation with linear accelerator. Imaging,technique and clinical indications]. (1998) (3)
- Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer (2021) (3)
- Gastrin-Releasing Peptide Receptor Antagonist [68Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer (2021) (3)
- The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event (2020) (3)
- OC-0061 EORTC 22113-8113 Lungtech trial on SBRT of central lung tumors (2019) (3)
- Dynamics of Tumor Hypoxia in Patients undergoing Radiochemotherapy for Head and Neck Cancer Evaluated with Serial 18F-fluoromisonidazole PET (2010) (3)
- O-16 HEPANOVA: Final efficacy and safety results from a phase 2 study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma (2021) (3)
- The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis (2022) (3)
- Multipotent mesenchymal stromal cells are sensitive to thermic stress – potential implications for therapeutic hyperthermia (2020) (3)
- A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa (2021) (3)
- The value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography for the treatment planning of malignant gliomas. (1999) (3)
- HEPANOVA: Final Efficacy and Safety Results from a Phase 2 Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant with Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (2022) (3)
- Oncogenic transgelin-2 is differentially regulated in isocitrate dehydrogenase wild-type vs. mutant gliomas (2018) (3)
- Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites (2021) (3)
- Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer—A Secondary Analysis of the PET Plan Trial (2020) (2)
- ACTR-49. PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA (2018) (2)
- Imaging for radiation treatment planning and monitoring in prostate Cancer: Precision, personalization, individualization of therapy (2019) (2)
- Response Monitoring by Positron Emission Tomography during Radiotherapy of a Squamous Cell Skin Carcinoma (2005) (2)
- PET/CT Imaging in Prostate Cancer: Indications and Perspectives for Radiation Therapy (2014) (2)
- Treatment outcomes of elderly salivary gland cancer patients undergoing radiotherapy - results from a large multicenter analysis. (2020) (2)
- Genomic classifiers in personalized prostate cancer radiotherapy approaches - a systematic review and future perspectives based on international consensus. (2022) (2)
- Abdominal Stereotactic Body Radiotherapy: Local Control and Correlationto Biologically Equivalent Dose (2016) (2)
- One-year-results after fractionated radiotherapy in choroidal neovascularisation in age-related macula degeneration (1998) (2)
- [Radiotherapy of brain tumors. New techniques and treatment strategies for]. (2010) (2)
- Recommendation of Regional Hyperthermia in the Treatment of Breast Cancer (2021) (2)
- Convolutional neural network based deep-learning architecture for intraprostatic tumour contouring on PSMA PET images in patients with primary prostate cancer (2020) (2)
- Malignant Glioma Delineation in Amino Acid PET-Images Using a 3D Random Walk Approach (2013) (2)
- PO-0848: Simultaneous integrated protection (SIP): a new concept for high precision radiation therapy (2016) (2)
- The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly (2021) (2)
- Development of a Hypoxia-Immune Prognostic Classifier for Head-and-Neck Cancer Patients Undergoing Radiotherapy - Results From a Prospective Imaging Trial. (2021) (2)
- Anti-angiogenics and Radiation Therapy (2019) (2)
- Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial (2022) (2)
- Hyperthermia Plus Re-Irradiation in the Management of Unresectable Locoregional Recurrence of Breast Cancer in Previously Irradiated Sites. (2020) (2)
- P2.17-19 Quality of Life After Pulmonary Stereotactic Fractionated Radiotherapy: Longterm Results of the Phase II STRIPE Trial (2019) (2)
- Correction to expert consensus on re-irradiation for recurrent glioma (2018) (2)
- Human mesenchymal stromal cells maintain their stem cell traits a,fter high-LET particle irradiation - Potential implications for particle radiotherapy and manned space missions. (2021) (2)
- Does overall treatment time impact on survival after whole-brain radiotherapy for brain metastases? (2011) (2)
- Interference between mutational load, immune signatures and outcome in patients with head and neck cancer treated with definitive chemoradiation: A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2018) (2)
- Progression-Free Survival, Prognostic Factors, and Surgical Outcome of Spheno-Orbital Meningiomas (2021) (2)
- 18F-FMISO PET/CT visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine (2014) (2)
- [Interdisciplinary expert consensus on innovations in imaging diagnostics and radionuclide-based therapies for advanced prostate cancer]. (2021) (2)
- [Automated delivery of codes for charge in radiotherapy]. (2010) (2)
- OC-0598: FDG-PET-guided target volume reduction for isotoxic dose escalation in LA NSCLC (PET-Plan study) (2018) (2)
- Discovery of a reliable and robust methylome classifier of HPV driven head and neck cancer with favorable response to chemoradiation: A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2018) (2)
- Efficacy of re-irradiation with carbon ions (RiCi) in patients with recurrent high-grade glioma (rHGG) compared to the standard re-irradiation with photons (RiP): The reference multicenter cohort of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2019) (2)
- LINAC-Radiosurgery versus Stereotactic Fractionated Radiotherapy in Patients With Acoustic Neuromas: Results of a Prospective Study of 101 Patients Treated in a Single Institution (2007) (2)
- Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial (2021) (2)
- [Stereotactic radiation therapy with a modified linear accelerator in patients with brain metastases]. (2001) (2)
- Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas. (2017) (2)
- Radiotherapy for Pituitary Adenomas (2003) (2)
- A Retrospective Evaluation of the Retrosigmoidal Approach for Petroclival Meningioma Surgery and Prognostic Factors Affecting Clinical Outcome (2022) (2)
- Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma (2022) (1)
- Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2019) (1)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (1)
- Scientific impact of studies published in temporarily available radiation oncology journals: a citation analysis (2015) (1)
- Tumor Volume Reduction From 3 Gy-Fractions in Brain Metastases and Implications for Combined Treatment (2005) (1)
- Good Long-term Quality of Life (QOL) Preservation after Pulmonary Stereotactic Fractionated Radiation Therapy (SBRT) in Frail Patients: Prospective Phase II Stripe Trial (2018) (1)
- Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous (2019) (1)
- 305 TUMOR HYPOXIA IN HEAD AND NECK CANCER DURING RADIOCHEMOTHERAPY EVALUATED WITH SERIAL [18F] -FLUOROMISONIDAZOLE PET (2012) (1)
- Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients (2022) (1)
- 18F-Octreotate positron emission tomography (PET) for target volume delineation in stereotactic radiation therapy planning of glomus tumors (2007) (1)
- Stereotactic fractionated radiotherapy and linac-radiosurgery in the treatment of vestibular schwannoma (2004) (1)
- Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival. (2019) (1)
- Customized treatment of recurrent gynaecological cancer--the need for intraoperative radiation therapy. (2016) (1)
- Tumor Heterogeneity in Gliomas – a Histopathology-Targeted Proteomic Pilot Study (2019) (1)
- Treatment planning for conformal stereotactic radiotherapy (1999) (1)
- Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy. (2022) (1)
- Improved Oxygenation of Human Skin, Subcutis and Superficial Cancers Upon Mild Hyperthermia Delivered by WIRA-Irradiation. (2022) (1)
- Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation (2022) (1)
- OC-0260: Stereotactic body radiotherapy (SBRT) in pancreatic cancer: What is the therapeutic window? (2014) (1)
- Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-14, ARO 2015–3, DKTK-ROG) (2020) (1)
- Radiotherapy for nonagenarians: the value of biological versus chronological age (2020) (1)
- PO-0966 Sarcopenia as prognostic marker in elderly HNSCC patients undergoing (chemo-)radiation (2021) (1)
- EP-1240: Normal tissue exposure in SBRT: Retrospective QA on a prospective cohort - what have we learned? (2016) (1)
- Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET (2018) (1)
- miR-219a-2-3p Functions As A Tumor Suppressor In IDH Wild-Type Gliomas By Inhibiting TBK1 (2020) (1)
- Stereotactic radiation therapy in melanoma brain metastasis: A European, multicentric cohort. (2018) (1)
- Hypoxia and positron emission tomography in patients with gliomas (2017) (1)
- Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns (2014) (1)
- Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters (2022) (1)
- PO-0818: Focal IMRT dose escalation for prostate cancer using PSMA PET/CT and MRI: a planning study (2018) (1)
- [Morbidity and mortality due to meningioma after cranial radiotherapy]. (2018) (1)
- Biological imaging for individualized therapy in radiation oncology: part I physical and technical aspects. (2018) (1)
- Advanced Imaging Modalities and Treatment of Gliomas: Radiation Therapy (2014) (1)
- FDG-PET for radiation treatment planning in patients with lung metastases (2010) (1)
- EP-1369: High local control for lung SBRT of comorbid patients: prospective monocenter phase II STRIPE trial (2018) (1)
- EP-2030 Multiparametric MRI and FMISO PET in HNSCC and its relation with outcome (2019) (1)
- Stereotactic radiosurgery (SRS) for brain metastases: a systematic review (2014) (1)
- Abstract CT186: HEPANOVA: Interim safety analysis from a phase 2 study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma (HCC) (2020) (1)
- 2388 : Non-Invasive Imaging of Alpha-v-Beta-3-Expression in Head-and-Neck Cancer Patients With (18F)Galacto-RGD and Positron Emission Tomography (2006) (1)
- Single punch, double biopsy (2016) (1)
- Mathematical Description of Changes in Tumour Oxygenation from Repeated Functional Imaging. (2018) (1)
- Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review) (2022) (1)
- PO-0749: Early impact of pulmonary SBRT on Quality of Life: Benefit for patients with low initial QoL/GHS (2017) (1)
- OC-0561 WHOLE BRAIN IRRADIATION WITH HIPPOCAMPAL SPARING AND DOSE ESCALATION ON MULTIPLE BRAIN METASTASES (2012) (1)
- A 6-gene signature for outcome prediction of grade II/III glioma. (2014) (1)
- CTNI-38. PriCoTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA (2021) (1)
- The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation (2022) (1)
- Comparative Analyses of Two Established Scores to Assess the Stability of Spinal Bone Metastases Before and After Palliative Radiotherapy (2021) (1)
- Role of PET Imaging in Patients with High-Grade Gliomas undergoing anti-angiogenic Therapy with Bevacizumab – Review of the Literature and Case Report (2014) (1)
- Effects of radiotherapy and chemotherapy on sensory deficits from spinal cord damage (2005) (1)
- Timeline Of Hippocampal Atrophy Following Whole-Brain Radiation Therapy With And Without Hippocampus Avoidance (2020) (1)
- Validation of a method for automatic image fusion (BrainLAB System) of CT-data and C11-Methionin-PET data for stereotactic fractionated radiotherapy using a LINAC (2001) (1)
- Value of PET imaging for radiation therapy (2021) (1)
- A Voxel-Wise Comparison of 68ga-Hbed-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: Implementations for Radiation Therapy Treatment Planning (2016) (1)
- A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT (2022) (1)
- Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil (2012) (1)
- The value of IMT-SPECT investigation in the target volume definition of brain gliomas (1998) (1)
- Tumor volume in prostate cancer assessed by [11C]Choline PET/CT: Validation with surgical specimen (2010) (1)
- Necroptosis-dependent immunogenicity of cisplatin: implications for enhancing the radiation-induced abscopal effect. (2022) (1)
- Abstract CT106: PriCoTTF trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma (2020) (1)
- PO-0801: Hippocampal-avoiding WBRT selectively prevents hippocampal atrophy as determined by automated volumetry (2015) (1)
- The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond? (2021) (1)
- Recommendation of human spinal cord reirradiation dose based on data from 39 patients (2003) (1)
- Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies (2021) (1)
- Management of Medial Sphenoid Wing Meningioma Involving the Cavernous Sinus: A Single-Center Series of 105 Cases (2022) (1)
- PATH-19. TUMOR HETEROGENEITY IN GLIOMAS: A PILOT STUDY OF HISTOPATHOLOGY-ASSOCIATED PROTEOME PROFILES ASSESSED BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF FFPE SAMPLES (2019) (1)
- PO-0815 Stereotactic radiation therapy in colorectal cancer brain metastasis: a multicentric cohort (2019) (1)
- Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses (2022) (1)
- PH-0168 Hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma. (2021) (0)
- EP-1437 The prognostic significance of neutrophil / lymphocyte ratio for SBRT of cholangiocellular carcinoma (2019) (0)
- Abstract CT084: HEPANOVA: A phase II trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma (2018) (0)
- Stereotactic Body Radiotherapy vs Transarterial Chemoembolization In Locally Advanced Hepatocellular Carcinoma (HERACLES: Hepatocellular Carcinoma Stereotactic Radiotherapy Clinical Efficacy Study) (2020) (0)
- Metastasis-free survival after salvage radiotherapy for post-operative prostate cancer patients in the PSMA PET/CT era – a multicenter analysis (2021) (0)
- EP-1218: Comparing diffusion weighted MRI with amino acid PET for re-irradiation in recurrent glioblastoma (2018) (0)
- Electronic Poster: Clinical track: Head and neckEP-1138 Reirradiation, cetuximab and itraconazole in locally recurrent and unresectable head and neck cancer (2015) (0)
- PO-0793 EXPERT PANEL REVIEW OF FDG-PET/CT IN NSCLC: IMPROVEMENT OF INTER-, INTRAOBSERVER VARIABILITY BY HARMONIZATION (2012) (0)
- OC-0629 A hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing radiotherapy (2021) (0)
- GENE-27. GENOME-WIDE DNA METHYLATION PROFILING IN GRADE II AND III GLIOMAS REVEALS A SUBSET OF GENES WITH PROGNOSTIC SIGNIFICANCE CONTROLLED BY PROMOTER METHYLATION (2018) (0)
- 11PPrognostic significance of different immunohistochemical markers in small cell lung cancer (2017) (0)
- Convolutional neural networks for head and neck tumor segmentation on 7-channel multiparametric MRI: a leave-one-out analysis (2020) (0)
- CSIG-02. MOLECULAR PROFILING IDENTIFIES INCREASED TRANSGELIN-2 EXPRESSION IN LOW(ER) GRADE GLIOMAS WITH WILD-TYPE IDH1/2 VS. MUTANT IDH1/2 (2017) (0)
- PD-0664: Outcome and toxicity of RT in elderly HNSCC patients –experience from a large monocentric cohort (2020) (0)
- Carcinomatous Meningitis Appearing as Acoustic Neuromas Two Cases (0)
- A Methylome Classifier Identifies Patients at Risk for Locoregional Recurrence after Adjuvant Radiochemotherapy in HPV-DNA negative HNSCC: a Multicenter Trial of the German Cancer Consortium- Radiation Oncology Group (DKTK-ROG) (2019) (0)
- OC-0451: Tumour volume, hypoxia and cancer stem cells as prognosticators for LRC after primary RCT in HNSCC (2016) (0)
- PO-1172: dose effects due to interfractional variability for hypofractionated radiotherapy of prostate cancer (2020) (0)
- PSMA-PET- and mpMRI-guided focal radiation dose escalation in primary prostate cancer patients – a planned safety analysis of a two-armed prospective phase II trial (HypoFocal) (2021) (0)
- O-(2-(F-18)fluorethyl)-L-tyrosin: A practicable aminoacid tracer for tumour volume definition by means of positron-emission-tomography in ZNS tumours (2005) (0)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (0)
- Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results? (2023) (0)
- DRUG-SPECIFIC MODULATION OF 11C-CHOLIN UPTAKE IN HUMAN PROSTATE CANCER CELL LINES (2006) (0)
- Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer – a prospective pilot study (2020) (0)
- Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients (2022) (0)
- EP-1388: Upper abdominal stereotactic radiotherapy (SBRT): Correlation of local control with biological equivalent dose (2014) (0)
- ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy (2020) (0)
- IMT-SPECT in gliomas: correlation with survival and consequences for target volume definition (2001) (0)
- PO-0729 SMALL VOLUME REIRRADIATION AND CETUXIMAB FOR RECURRENT HEAD AND NECK CANCER (2012) (0)
- 18F-misonidazole Pet Tumor Hypoxia Imaging During Chemoradiation Therapy For HNSCC - Correlation To Outcome (2014) (0)
- Radiotherapy Versus Chemoradiation in Elderly Head-and-Neck Squamous Cell Carcinoma Patients – A Retrospective International Multicenter Study (2022) (0)
- PO-1227 Impact of inflammation using blood parameters in HCC patients treated with SBRT (2021) (0)
- The Role of Different Chemotherapy Protocols for Concurrent CRT in Locally Advanced NSCLC (2020) (0)
- MP57-01 THE DIAGNOSTIC ACCURACY OF 68GA-PSMA-PET/CT FOR DETECTION OF LYMPH NODE METASTASES IN THE SETTING OF SALVAGE LYMPH NODE DISSECTION (2016) (0)
- Local Tumor Control and Survival after Hippocampus-Avoidance Whole-Brain Irradiation and Dose Escalation on Multiple Brain Metastases (2019) (0)
- PH-0438 Effects of particle irradiation on human mesenchymal stromal cells (2021) (0)
- PO-1556: 4D-PET radiomics-features for radiotherapy treatment monitoring in locally advanced NSCLC patients (2020) (0)
- PO-0824: IMRT dose painting for prostate cancer using PSMA-PET/CT: a planning study based on histology (2017) (0)
- PO-1231 Response to neoadjuvant RCT as a predictor for overall survival in therapy of esophageal cancer (2021) (0)
- 7025 POSTER Long Term Outcome After Combined External Beam Radiotherapy and High Dose Rate Brachytherapy for Localized Prostate Cancer (2011) (0)
- The use of 18FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini review (2023) (0)
- Proffered Papers: Patient safety and treatment outcomePV-0551: PSMA PET/CT vs MRI for GTV delineation in prostate cancer: a comparison with histology (2017) (0)
- PD-0413: The role of different chemotherapy protocols for concurrent CRT in locally advanced NSCLC (2020) (0)
- PO-0989: Radiation therapy for thoracic malignancies: the impact on immune and vascular blood biomarkers (2020) (0)
- The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer (2020) (0)
- P1.04-52 The Role of Blood Biomarkers in Radiation Therapy for Thoracic Malignancies (2019) (0)
- Radiosurgery and Stereotactic Fractionated Radiotherapy in Vestibular Schwannoma (2005) (0)
- EP-1147 Hypoxia in SCCHN: is blood oxygenation (HB and EPO) a valuable biomarker in predicting local a/o distant failure? (2015) (0)
- EP-1146 Imaging in SCCHN: Can SUVmax of pretreatment FDG PET/CT in locally advanced SCCHN predict treatment outcome? (2015) (0)
- PO-114: Alterations in tumour hypoxia in serial FMISO/PET-CT during chemoradiation in HNSCC (2017) (0)
- Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study (2022) (0)
- Homogenous dose distribution and sparing of normal tissue in low dose regions with IMRT in fractionated stereotactic radiotherapy: a comparison with conformal static beam techniques (2004) (0)
- EP-1235: Necrosis / Fistulae occurring in temporal association with chest irradiation (2016) (0)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (0)
- Xerostomia: Association Between Saliva Production and Patient-reported Grading (2012) (0)
- Expert consensus on re-irradiation for recurrent glioma (2017) (0)
- The Role of Particle Therapy for the Treatment of Skull Base Tumors and Tumors of the Central Nervous System (CNS) (2019) (0)
- EP-1263: Evaluation of an offline adaptive IGRT protocol for prostate cancer (2013) (0)
- PO-1733: Validation of PSMA-PET/CT based contouring techniques for intraprostatic tumor definition (2020) (0)
- Stereotactic external beam radiotherapy of brain metastases — Clinical results of a prospective study (1997) (0)
- SIP: The Concept of Simultaneous Integrated Protection for High-Precision Radiation Therapy (2016) (0)
- The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma (2017) (0)
- PO-0619: Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC (2017) (0)
- Value of PET imaging for radiation therapy* Wertigkeit der PET-Bildgebung für die Radioonkologie (2021) (0)
- EP-1247: Is CC Chemokine Ligand 18 a biomarker for the prediction of radiation induced lung disease? (2016) (0)
- OA12.05 Imaging-Guided Target Volume Reduction in Radiotherapy of Lung Cancer: The Prospective Randomized Multinational PET-Plan Trial (2019) (0)
- 19 INVITED Application of Hypoxia Imaging in Radiation Treatment Planning (2011) (0)
- Radiomic Features from PSMA PET for Intraprostatic Tumor Discrimination and Characterization in Patients with Prostate Cancer. a Comparison Study with Histology Reference (2019) (0)
- Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy (2020) (0)
- Accelerated Hyper-Versus Normofractionated Radiochemotherapy with Temozolomide in Patients with Glioblastoma: A Multicenter Retrospective Analysis. (2021) (0)
- OC-0627 TCP predictions of an automated dose painting strategy based on FDG and FMISO PET imaging (2022) (0)
- Imaging Biomarkers Multiparametric 3 Tesla MRI and FMISO Hypoxia PET during Chemoradiotherapy in HNSCC and Their Relation to Outcome (2019) (0)
- PO-0969 4D-PET/CT FOR TARGET VOLUME DELINEATION IN STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR MALIGNANT LUNG LESIONS (2012) (0)
- PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. (2023) (0)
- Multicentric Evaluation of Long-term Outcome After Highly Advanced Single-Dose or Fractionated Radiation Therapy in Patients With Vestibular Schwannomas: Pooled Results From 3 Large German Centers (2013) (0)
- Abstract CT175: HEPANOVA Phase II study design for advanced hepatocellular carcinoma: Tumor treating fields concomitant with sorafenib (2019) (0)
- 316Brain gliomas advantages of the 3-dimensional treatment planning (1996) (0)
- Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? (2018) (0)
- PV-0510: FMISO-PET/CT and functional MRI parameters as biomarkers during chemoradiation of HNSCC (2017) (0)
- PD-0296: Pancreatic cancer: Comparison of toxicity of IMRT and 3D-conformal radiotherapy (3D-CRT) (2014) (0)
- PO-076: Combined Reirradiation and Cetuximab for Locally Recurrent Head and Neck Cancer ñ Mature Overal Survival Results (2013) (0)
- Three-dimensional treatment planning of brain gliomas: A dosimetric study of cerebral irradiation (1997) (0)
- PO-1186: Impact of a low FODMAP diet on rectal gas and rectal volume during radiotherapy of prostate cancer (2020) (0)
- EP-1667: IGRT of the Prostate ñ Evaluation of gold marker position migration during treatment course (2014) (0)
- Radiosurgery versus microsurgery in the treatment of brain metastases (2004) (0)
- PO-0650: Dynamics of tumor hypoxia in serial 18F-Misonidazole PET for SCCHN during chemoradiation and correlation to outcome (2015) (0)
- Validation of the SUV values calculation in the iPlan 4.0 Treatment Planning System (BrainLAB) (2009) (0)
- Abstract 4312: A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy (2015) (0)
- EP-1528 Feasibility and toxicity of focal dose escalation on multimodally defined GTVs in prostate cancer (2019) (0)
- PO-1035: Central hepatobiliary toxicity after liver SBRT and hypo-fractionated Radiotherapy (2020) (0)
- EP-1253: Interobserver variability in the target delineation of hepatocellular carcinoma (2017) (0)
- PD-0874 Impact of dose and prescription method in SBRT of NSCLC. A pooled analysis of 2 prospective trials. (2021) (0)
- A novel multi-SNP model predictive of erectile dysfunction following radiotherapy in prostate cancer (2016) (0)
- PD-0433: Acute and late complications of radiotherapy in women with implant-based breast reconstruction (2015) (0)
- Ten Year Survival and Quality of Life after Combined High-Dose-Rate Brachytherapy Boost (HDR-BT) and External Beam Radiotherapy (EBRT) for Localized Prostate Cancer (2010) (0)
- 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy (2022) (0)
- PO-1524: FET-PET radiomics predicting outcome after re-irradiation in recurrent glioblastoma (2020) (0)
- Voxel-based PSMA-PET/histopathology analysis in patients with primary prostate cancer (2016) (0)
- EP-1455: Interobserver and interfraction variability using free-breathing cbCT for SBRT of the upper abdomen (2018) (0)
- Correlative Analyses Between Immune Markers, Tumor Hypoxia And Outcomes Of Head-And-Neck Cancer Patients Undergoing Chemoradiation: Results From A Prospective Trial (2020) (0)
- [Combination of percutaneous radiotherapy, brachytherapy, and androgen deprivation equivalent alternatives to radical prostatectomy for prostate cancer]. (2018) (0)
- PO-0779: SIB-SIP: Combined simultaneous integrated boost and protection for upper abdominal SBRT (2015) (0)
- Radiotherapy for brain tumors – New techniques and treatment strategies (2012) (0)
- PO-113: Dynamics of biological imaging parameters in PW-MRI and FMISO-PET/CT during chemoradiation of SCCHN (2017) (0)
- GENO-08NEXT GENERATION SEQUENCING REVEALS DISTINCT PROGNOSTIC CLASSES AMONG GRADE II/III GLIOMAS. (2015) (0)
- OC-0275 Safety and efficacy of concurrent SRT and targeted- or immunotherapy for melanoma brain metastases (2019) (0)
- EP-1432: Safety of repeated stereotactic body radiotherapy (SBRT) for recurrent liver malignancies (2018) (0)
- Ophthalmological Changes in Patients With Benign Brain Tumors After Stereotactic Fractionated Radiotherapy (2005) (0)
- PO-0838: Impact of collimator leaf width and VMAT optimization algorithm on whole brain irradiation with hippocampal sparing (2014) (0)
- PO-0652: SFRT of the resection cavity in patients with one to three brain metastases (2016) (0)
- [Intraoperative radiotherapy in abdominal surgery-Own experiences]. (2020) (0)
- 32 Radiotherapy for high-grade glioma: Is altered fractionation beneficial? (2003) (0)
- PO-1050: SBRT in liver cancer versus TACE. A prospective, non-randomised observational trial (HERACLES) (2020) (0)
- EP-1655 Cost-effectiveness analysis of stereotactic radiotherapy in colorectal cancer brain metastases (2019) (0)
- Evaluation and Comparison of Segmentation Algorithms in Low Contrast FET-PET Scans for Gross Tumor Volume Delineation (2014) (0)
- PH-0217 Synergistic use of combined FDG and FMISO PET/CT imaging for personalized dose prescription (2021) (0)
- PO-1348 Urethral sparing increases the therapeutic ratio in dose escalated hypofractionated radiotherapy (2021) (0)
- Development and External Validation of a Prognostic Classifier for Elderly Head-and-Neck Cancer Patients Undergoing (Chemo)radiation. (2021) (0)
- PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis (2019) (0)
- EP-1465 DOSE ADAPTED TREATMENT WITH IGRT FOR PELVIC CARCINOMA WITH LYMPH NODE INVOLVEMENT (2012) (0)
- BI-12RTOG 0525 RECURSIVE PARTITIONING ANALYSIS BASED ON CLINICAL AND PROTEIN BIOMARKER PARAMETERS (2014) (0)
- Radiotherapy and Imaging (2014) (0)
- Fractionated radiotherapy for pituitary adenomas (2021) (0)
- In-Silico Discovery of Novel Small-Molecule Inhibitors Targeting Transgelin-2-Actin Interaction Inhibits Proliferation, Invasion and Improves Chemo-Radiation Response in Human Glioblastoma. (2021) (0)
- OC-0231: Outcome impact of radiotherapy protocol compliance: RTQA results from the PET-Plan trial (2020) (0)
- Randomized Controlled Clinical Trials in Radiation Therapy: Patterns of Publication in the Most Frequently Cited Studies (2015) (0)
- EP-1107: Treatment Strategies for local and distant recurrence after HFSRT of the Resection Cavity (2017) (0)
- Poster ViewingComprehensive mRNA Prognostic Biomarker Analysis of Grade 2/3 Gliomas (2017) (0)
- OC-0277 A 6-gene signature for loco-regional control prognosis in HNSCC patients treated by PORT-C (2021) (0)
- OC-0588: Validation of the reRT risk score (RRRS) in glioma patients: A multicenter DKTK/ROG analysis (2018) (0)
- Pulmonary Changes in FDG-PET/CT After Cure of Small Lung Tumors With Stereotactic Ablative Radiation Therapy (SBRT): Which Imaging Features Can Be Expected? (2013) (0)
- Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy (2023) (0)
- Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2020) (0)
- PO-0866 Cost-effectiveness analysis of stereotactic radiotherapy in melanoma brain metastases. (2019) (0)
- Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer (2022) (0)
- Stereotactic fractionated radiotherapy (SFR) and LINAC-radiosurgery (RS) in the treatment of vestibular schwannoma (VS) (2006) (0)
- The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly (2021) (0)
- Dynamics in 18-fluoromisonidazole PET/CT and perfusion-weighted 3-Tesla MRI parameters as biomarkers for predicting treatment outcome in HNSCC (2016) (0)
- Effect of HNSCC Radiochemotherapy on Imaging Biomarker T2* MRI and its Relation to FMISO-PET Derived Hypoxia (2018) (0)
- OC-0059 Stereotactic radiotherapy for oligoprogressive NSCLC: clinical scenarios affecting survival (2019) (0)
- 129 The impact of I-123-alpha-methyl-tyrosine spect in the planning of 3-D radiation treatment of brain gliomas (1999) (0)
- Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis (2022) (0)
- PO-0731: A miRNA-based predictive model in prostate cancer patients (2015) (0)
- Radiotherapeutic management of cervical lymph node metastases from an unknown primary site – experiences from a large cohort treated with modern radiation techniques (2020) (0)
- Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients (2022) (0)
- CTNI-29. INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL (2022) (0)
- EP-2059: Changes in hypoxia in serial F-MISO/PET-CT during chemoradiation in HNSCC (2016) (0)
- Improvement of diffusion weighted MRI by practical B0 homogenization for head & neck cancer patients undergoing radiation therapy. (2022) (0)
- PO-0926: Voxel-based PSMA-PET/histopathology analysis in patients with primary prostate cancer (2016) (0)
- EP-1230: Post-operative radiotherapy (PORT) in patients with resected non small cell lung cancer (NSCLC) (2017) (0)
- 788 The Influence of the Combined Treatment with 13-cis Retinoic Acid and Thalidomide on the Growth of U251 Glioblastoma Xenografts (2012) (0)
- OC-0276: Combining different genomic signatures to improve the prognostic power for LRC after PORT-C in HNSCC (2018) (0)
- Impact of tumour hypoxia and cancer stem cells on loco-regional control after primary radiochemotherapy in locally advanced HNSCC - results of a multicentre biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (2016) (0)
- P14.20 Local control an overall survival after frameless LINAC radiosurgery: a single center experience (2017) (0)
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (0)
- Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1) (2016) (0)
- PO-1695: The utility of multiparametric MRI to characterize hypoxic tumor subvolumes compared to FMISO PET/CT (2020) (0)
- Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy (2021) (0)
- EP-1086: Finding the right threshold for determining hypoxic subvolumes in F-MISO-PET/CTs for HNSCC (2016) (0)
- From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy (2023) (0)
- EP-1272: Stereotactic radiotherapy in pancreatic cancer. Review of two different treatment approaches (2016) (0)
- Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference (2018) (0)
- OC-0440: Impact of chemokine receptor CXCR4 and its ligand SDF1 expression on loco-regional control in HNSCC (2016) (0)
- Patients with multiple cerebral metastases treated with radiosurgery and microsurgery: Comparison of the treatment methods (2005) (0)
- Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma (2017) (0)
- Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial (2020) (0)
- Stereotactic Radiation Therapy in Colorectal Cancer Brain Metastasis: An International, Multicentric Cohort (2019) (0)
- Transgelin-2 Expression Increases Invasion, Proliferation and Radiation Resistance in IDH Wild-Type Gliomas (2018) (0)
- P-215 phase 2 HEPANOVA study of tumor treating fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma (HCC): Interim safety analysis (2020) (0)
- [Failure patterns following external beam radiotherapy with or without additional focal boost in the randomized FLAME trial for localized prostate cancer]. (2022) (0)
- Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients (2022) (0)
- 43 poster: Dynamics of Hypoxia in Head and Neck Cancer During Chemoradiotherapy Evaluated with [18]F-Fluoromisonidazole PET (2010) (0)
- [On the retirement of Prof. Dr. Michael Molls -- director of the Department of Radiation Oncology, University of Munich]. (2014) (0)
- PD-0921 Long-term quality of life of surviving elderly head-and-neck cancer patients after (chemo)radiation (2021) (0)
- Corrigendum to “HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)” [Radiother. Oncol. (2015) (0)
- Comparison of PSMA-PET/CT and Multiparametric MRI for Dose Painting Guidance in Patients With Primary Prostate Cancer Based on Comparison with Histology Reference (2017) (0)
- Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer: Simultaneus intergrated protection (SIP) versus conventional SBRT A toxicity review of two different treatment approaches. (2016) (0)
- The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage (2019) (0)
- Proteomic Biomarkers of Grade II and Grade III Gliomas. (2016) (0)
- HYPOXIA-BASED ADAPTIVE TREATMENT PLANNING: THE IMPACT OF THE IMAGE REGISTRATION METHOD (2022) (0)
- OC-0162 PSMA PET/CT for intraprostatic tumor delineation and characterization based on radiomic features (2019) (0)
- Pharmacological Targeting Of Transgelin-2 As A Novel Strategy Of Therapeutic Intervention In Glioblastoma (2020) (0)
- PO-0636: Impact of DWI-MRI for gross tumor volume definition in patients with recurrent glioblastoma (2017) (0)
- Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition (2020) (0)
- PO-1541: Predictive treatment planning with SIP (simultaneously integrated protection) based on TCP and NTCP (2020) (0)
- EP-1605: Outcome and toxicity in a cohort of prostate cancer patients treated with image-guided radiotherapy (2018) (0)
- OC-0166 Cumulative metastases volume, not number of brain metastases predicts survival in melanoma patients (2019) (0)
- [Influence of adjuvant vs early salvage radiotherapy on lethality in men with high risk for recurrence following radical prostatectomy for prostate cancer]. (2021) (0)
- CSIG-21. THE ROLE OF miR-219a-2-3p AS A TUMOR SUPPRESSOR IN IDH1/2-WILD-TYPE GRADE II/III GLIOMAS (2018) (0)
- Tumor Imaging with Special Emphasis on the Role of Positron Emission Tomography in Radiation Treatment Planning (2009) (0)
- 1491 poster MULTIMODAL DOCUMENT- AND IMAGE MANAGEMENT IN RADIOTHERAPY. HOW TO HANDLE DOCUMENTS AND CLINICAL IMAGES IN A GENUINE DIGITAL ENVIRONMENT (2011) (0)
- PO-0693: Primary tumor response of locally advanced NSCLC in PET/CTs during radiochemotherapy (2016) (0)
- PO-0767: Local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (0)
- Locally Advanced Non-Small Cell Lung Cancer: Excellent Results of Isotoxic Dose Escalation after FDG-PET-Guided Target Volume Reduction – Results of a Prospective Randomized Multicenter Trial (2018) (0)
- Evaluation of High-Risk Imaging Features for Detection of Local Progression after Stereotactic Body Radiotherapy (SBRT) of Malignant Pulmonary Lesions in the prospective STRIPE -trial (2019) (0)
- Use of Neuroimaging Techniques in Glioma Patients – Results of an International Survey on behalf of the EORTC Brain Tumor Group (2022) (0)
- EP-1439 The role of FDG PET / CT in SBRT of primary tumors in the upper abdomen (2019) (0)
- Abstract 3156: Tumor Treating Fields reduce cellular survival of human mesenchymal stromal cells via apoptosis and senescence induction (2022) (0)
- PO-102: Reirradiation and cetuximab in patients with recurrent, unresectable previously irradiated head and neck cancer (2015) (0)
- Using C11-Met-PET to determine GTV for re-irradiation in recurrence of high grade gliomas (Preliminary results of a phase-I/II study) (2004) (0)
- Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET (2018) (0)
- [10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]. (2021) (0)
- DNA-Methylome based Tumor Hypoxia Classifier Identifies HPV-negative Head & Neck Cancer Patients at Risk for Locoregional Recurrence After Primary Radiochemotherapy. (2023) (0)
- CTNI-79. PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA (2020) (0)
- EP-1249: A therapeutic challenge: metastatic pancreatic cancer with musculoskeletal predilection. Case report and review (2014) (0)
- Measuring breathing induced oesophageal motion and its dosimetric impact (2020) (0)
- IB-U-Nets: Improving medical image segmentation tasks with 3D Inductive Biased kernels (2022) (0)
- EP-1580 Adjuvant radiotherapy in prostate cancer patients–bRFS and toxicity using adaptive IMRT technique (2019) (0)
- PO-1329 Longterm Biochemical Recurrence-Free Survival after PSMA-PET/CT–Based Salvage Radiotherapy (2021) (0)
- OC-0320: Correlations of tissue and imaging hypoxia biomarkers during chemoradiation of HNSCC patients (2020) (0)
- Recurrence Analysis of Glioblastoma Cases Based on Distance and Dose Information. (2023) (0)
- Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice (2023) (0)
- PO-0786: Can we derive the radiation target volume for moving lesions from 3D-PET? (2015) (0)
- PET/CT and MRI guided salvage radiotherapy after prostatectomy for prostate cancer (2016) (0)
- Gastrin-releasing peptide receptor antagonist [Ga-68]RM2 PET/CT for staging of pre-treated, metastasized breast cancer (2022) (0)
- OC-0583: Time evolution of the hypoxic compartment on sequential FMISO PET images (2020) (0)
- Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial (2020) (0)
- 1116 POSTER The Influence of the Combined Treatment With Vadimezan (ASa 404) and Taxol on the Growth of U251 Glioblastoma Xenografts (2011) (0)
- Immunohistochemistry and Radiomics Features for Survival Prediction in Small Cell Lung Cancer (2020) (0)
- EP-1522 Radiotherapy with or without antihormonal therapy for PSMA-positive oligorecurrent prostate cancer (2019) (0)
- PO-1014 Prognosis classifier for elderly head-and-neck squamous cell carcinoma patients (2021) (0)
- 7009 POSTER DISCUSSION Sensitivity and Specifity to Detect Local Recurrent Prostate Cancer Using Dynamic Contrast Enhanced (DCE) MRI Without Endorectal Coil and MRI Patterns of Post-prostatectomy Recurrence and of Its Response to Salvage Radiotherapy (2011) (0)
- Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy (2020) (0)
- PD-0429: Multireader study on 4DPET/CT target volume delineation in SBRT patients with central versus peripheral lung tumors (2015) (0)
- Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer (2023) (0)
- 563 The diagnostic accuracy of 68Ga-PSMA-PET/CT for detection of lymph node metastases in the setting of salvage lymph node dissection (2016) (0)
- OC-0390 TCGA molecular subclassification is prognostic for LRC of HNSCC after postoperative RCTx (2019) (0)
- Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients (2022) (0)
- PO-1211: Stereotactic radiotherapy combined with immune- or targeted therapy for renal cell cancer patients. (2020) (0)
- 14 PET in radiotherapy planning and monitoring (2005) (0)
- OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial (2019) (0)
- EP-1597: Focal dose escalation in prostate cancer with PSMA-PET/CT and MRI: planning study based on histology (2017) (0)
- PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (0)
- Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy in recurrent prostate cancer. (2023) (0)
- App-Controlled Treatment Monitoring and Support for Head and Neck Cancer Patients (APCOT): Protocol for a Prospective Randomized Controlled Trial (Preprint) (2020) (0)
- Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRI (2020) (0)
- Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection (2018) (0)
- The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts (2012) (0)
- FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? (2021) (0)
- EP-0991 MYOCARDIAL PERFUSION DEFECTS FOLLOWING RADIOTHERAPY FOR BREAST CANCER DETECTED BY 99MTC-MIBI-SPECT/CT (2012) (0)
- Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma (2017) (0)
- The Impact of Radiotherapy Protocol Adherence on the Treatment Outcome in Patients With Locally Advanced NSCLC Treated With Concurrent Chemoradiation: Results From the Radiotherapy Quality Assurance of the International Randomized PET-Plan Trial. (2021) (0)
- Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly? (2020) (0)
- OC-0093: Hippocampus-avoidance whole-brain irradiation with dose escalation on multiple brain metastases (2020) (0)
- RADIATION-INDUCED DEFECTS IN MYOCARDIAL PERFUSION AFTER THERAPY FOR LEFT-SIDED BREAST CANCER EVALUATED WITH 99 MTC-MIBI-SPECT/CT (2011) (0)
- EP-2296: Effect of radiochemotherapy on T2* MRI signal in HNSCC and its relation to FMISO-PET derived hypoxia (2018) (0)
- EP-1862: Impact of 4DPET/CT on normal tissue sparing for SBRT of central lung tumors (2016) (0)
- EP-1387: Outcomes after recurrent bladder cancer and (chemo)radiotherapy post TUR-B vs cystectomy (2016) (0)
- PH-0659 Metastasis-free survival after salvage radiotherapy in post-operative prostate cancer patients in the PSMA PET/CT era – a bi-institutional, retrospective analysis (2021) (0)
- 554 Does salvage lymphadenectomy for biochemical progression following radical prostatectomy and additional radiotherapy has an impact on overall survival? Initial results from a case-control study (2016) (0)
- Re: Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. (2022) (0)
- Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly (2023) (0)
- 1160 poster EVALUATION OF THE PET-DATA QUANTIFICATION IN THE RADIOTHERAPY TREATMENT PLANNING SYSTEM (2011) (0)
- Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (0)
- PO-1169: Influence of localisation of PSMA-positive oligo-metastases on efficacy of metastasis-directed EBRT (2020) (0)
- PO-0726: Long term follow up of patients with meningioma after stereotactic radiation therapy (SRT) (2018) (0)
- Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer. (2022) (0)
- Biological imaging in radiation treatment planning for brain tumours (2004) (0)
- PD-0669: Uncovering multifocality – PSMA-PET radiomic features for detection of intraprostatic microlesions (2020) (0)
- OC-0582: Gene signatures predict loco-regional control after postoperative radiochemotherapy in HNSCC (2016) (0)
- Increased radiosensitivity and radiothermosensitivity of human pancreatic MIAPaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitorNVP-HSP990 (2013) (0)
- Abstract LB-362: A six-gene classifier stratifies low-grade glioma patients with wild-type IDH (2016) (0)
- OC-0570: Validating gene signatures in locally advanced HNSCC patients treated by PORT-C and in xenografts (2020) (0)
- Elderly Patients with Head-and-Neck Squamous Cell Carcinoma: A Comparison between Surgery and Primary (Chemo)radiation (2022) (0)
- PO-0819: High dose rate brachytherapy plus external beam radiotherapy for localized prostate cancer (2018) (0)
- PO-0861 Analysis of nodal and prostatic bed RT in oligorecurrent PC patients treated with PSMA-PETguided RT (2019) (0)
- Multi-Reader Evaluation of Manual Tumor Delineation for Recurrent Glioblastoma on FET-PET Scan: Impact of PET Windowing Settings (2014) (0)
- OC-0163 Risk classification for PSA relapse after PSMAPET-guided RT for oligorecurrent prostate cancer (2019) (0)
- Intraoperative Strahlentherapie – Indikationen und Optionen in der Viszeralchirurgie (2020) (0)
- Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA) (2020) (0)
- Hypofractionated stereotactic re-irradiation of recurrent high-grade gliomas guided by amino-acids-PET(SPECT)/MRI/CT image fusion (2003) (0)
- C-11-choline PET/CT to monitor neoadjuvant androgen deprivation therapy and definitive radiotherapy in prostate cancer patients (2009) (0)
- [Intraoperative radiotherapy-Indications and options in visceral surgery]. (2020) (0)
- EP-1915 Modelling framework for FMISO and FDG PET imaging tailored dose prescription (2019) (0)
- 448 Single centre experience with 100 salvage lymph node dissections for treatment of nodal prostate cancer recurrence (2015) (0)
- External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer (2022) (0)
- Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis (2021) (0)
- EP-1313 PET-BASED GTV CONTOURING: WAYS FOR IMPROVEMENT OF THE INTER-OBSERVER VARIABILITY IN MANUAL CONTOURING (2012) (0)
- OC-0208: Comparison between 68Ga-PSMA-PET/CT and mpMRI for radiotherapy planning in primary prostate cancer (2020) (0)
- OC-0324: Immune contexture in SCCHN and outcome after chemoradiotherapy in an uni- and multicentric cohort (2018) (0)
- Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis (2022) (0)
- Implementation of PSMA-PET in focal dose-escalated radiotherapy of primary prostate cancer patients: Results of a planned safety analysis of a phase II trial. (2022) (0)
- Abstract 889: MicroRNA-21-5p upregulation in urine samples serves as novel biomarkers for early stage renal cell carcinoma patients diagnosis (2014) (0)
- Personalized Prognostic microRNA Models for Lower Grade Gliomas. (2016) (0)
- PO-1808: Effects of photon, carbon ion and ultraviolet radiation on human mesenchymal stem cells (2020) (0)
- OC-0293 TNT in rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial (2021) (0)
- Treatment of Benign Meningiomas with Stereotactic Fractionated Radiotherapy (2005) (0)
- EP-1252: Oligometastatic NSCLC: long-term results show efficiency of radical approaches in selected patients (2016) (0)
- PO-0930: Influence of inhomogeneous radiosensitivity and intrafractional movement on TCP in prostate cancer (2018) (0)
- Regional Recurrence after Stereotactic Fractionated Radiotherapy of Early Stage NSCLC: Results from a Prospective Phase II Study (STRIPE) (2020) (0)
- Recent advances of PET imaging in clinical radiation oncology (2020) (0)
- Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer (2014) (0)
- Further development of the iPlan planning system (BrainLAB) through determination of SUV values from PET data (2006) (0)
- Interference between tumor mutational burden, HPV status, immune signatures and outcome in patients with head and neck cancer treated with chemoradiotherapy: Results from a multicenter retrospective study of the German Cancer Consortium Radiation Oncology (2018) (0)
- EP-1504: Stability of gold marker position during IGRT of prostate cancer (2015) (0)
- EP-1106: Local control and overall survival after frameless radiosurgery (2017) (0)
- Abstract 2781: Novel putative diagnostic methylation biomarkers for prostate cancer identified by whole genome DNA methylation profiling (2016) (0)
- IMT-SPECT in brain gliomas: correlation with survival and consequences for irradiation treatment planning (2001) (0)
- Radiation Therapy in Brain Metastasis of Solid Tumors: A Challenge for the Future (2018) (0)
- Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA) (2017) (0)
- EP-1382: PET/CT and MRI guided salvage radiotherapy after prostatectomy for prostate cancer (2016) (0)
- HEPANOVA: A phase 2 trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma - Trial in progress. (2018) (0)
- 187 Hypoxia-pet for radiation treatment planning in head and neck cancer (2006) (0)
- The Role of Stereotactic Body Radiotherapy (SBRT) in Locally Advanced Hepatocellular Carcinoma Versus Transarterial Chemoembolization (TACE): A Prospective, Non-Randomized Observational Trial (HERACLES) (2019) (0)
- PO-1525: Immunohistochemistry and radiomics features for survival prediction in small cell lung cancer (2020) (0)
- EP-1868: Standardization of amino-acid PET windowing for GTV definition in recurrent glioblastoma (2016) (0)
- EP-1563 PSMA-ligand based radiotherapy for lymph node relapsed prostate cancer after radical prostatectomy (2019) (0)
- PO-1448 International survey on the standard-of-care for (chemo-)radiation in elderly HNSCC patients (2021) (0)
- MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL (2020) (0)
- Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy? (2023) (0)
- Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. (2023) (0)
- 103 poster: Use of FDG-4D-PET-CT for the Delineation of Radiotherapy Target Volumes in Malignant Lung Lesions (2010) (0)
- Molecular Imaging in Photon Radiotherapy. (2020) (0)
- Brain metastases in patients under 50 years of age: retrospective analysis (2012) (0)
- Validation of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumor volume delineation in patients with primary prostate cancer based on comparison with histology reference (2016) (0)
- Radiate Once More. (2021) (0)
This paper list is powered by the following services:
Other Resources About Anca Grosu
What Schools Are Affiliated With Anca Grosu?
Anca Grosu is affiliated with the following schools:
